Efficacy and safety of a 4 year combination therapy of growth hormone and gonadotropin- releasing hormone agonist in children with a short predicted height.
Phase of Trial: Phase III
Latest Information Update: 06 Apr 2017
At a glance
- Drugs Somatropin (Primary) ; Triptorelin (Primary)
- Indications Short stature
- Focus Therapeutic Use
- 22 Sep 2014 New trial record